StonvexLoading…
StonvexCore line items from ALGT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.32B | $2.22B | $2.32B | $2.14B |
Operating Income | $37.17M | $-239.98M | $220.98M | $91.65M |
Net Income | $-44.70M | $-240.24M | $117.60M | $2.49M |
EPS (Diluted) | $-2.48 | $-13.49 | $6.29 | $0.14 |
Total Assets | $4.21B | $4.43B | $4.86B | $4.51B |
Total Liabilities | $3.16B | $3.34B | $3.53B | $3.29B |
Cash & Equivalents | $172.70M | $285.89M | $143.26M | $229.99M |
Free Cash Flow OCF − CapEx | $75.10M | $38.30M | $-105.23M | $-131.64M |
Shares Outstanding | 18.05M | 17.85M | 18.02M | 18.03M |